Defining Reprogramming Checkpoints from Single-Cell Analyses of Induced Pluripotency

Abstract

Summary: Elucidating the mechanism of reprogramming is confounded by heterogeneity due to the low efficiency and differential kinetics of obtaining induced pluripotent stem cells (iPSCs) from somatic cells. Therefore, we increased the efficiency with a combination of epigenomic modifiers and signaling molecules and profiled the transcriptomes of individual reprogramming cells. Contrary to the established temporal order, somatic gene inactivation and upregulation of cell cycle, epithelial, and early pluripotency genes can be triggered independently such that any combination of these events can occur in single cells. Sustained co-expression of Epcam, Nanog, and Sox2 with other genes is required to progress toward iPSCs. Ehf, Phlda2, and translation initiation factor Eif4a1 play functional roles in robust iPSC generation. Using regulatory network analysis, we identify a critical role for signaling inhibition by 2i in repressing somatic expression and synergy between the epigenomic modifiers ascorbic acid and a Dot1L inhibitor for pluripotency gene activation. : Tran et al. combine ascorbic acid, 2i, and Dot1l inhibition to robustly generate induced pluripotent stem cells. With single-cell transcriptomes, they define the transcriptional signature and key regulators of reprogramming cells. Using network analysis, they find 2i suppresses somatic while ascorbic acid and Dot1l inhibitor collaboratively upregulate pluripotency genes.